The National Blood Authority (NBA) has agreed arrangements with Grifols Australia Pty Ltd for the addition of a Gamunex 10% 40g/400mL vial size under the nation
Australia’s prothrombin complex concentrate (PCC), Prothrombinex-VF, will be changing in 2024 as one of 5 domestic plasma product transitions taking place acros
Xembify, a 20% concentration SCIg product supplied by Grifols Australia, will be available for supply under the national blood arrangements from January 2024.
